Hepatic hollow fiber (HF) bioreactors can be used to provide temporary support to patients experiencing liver failure. Before being connected to the patient's circulation, cells in the bioreactor must be exposed to a range of physiological O 2 concentrations as observed in the liver sinusoid to ensure proper performance. This zonation in cellular oxygenation promotes differences in hepatocyte phenotype and may better approximate the performance of a real liver within the bioreactor. Polymerized human hemoglobin (PolyhHb) locked in the tense quaternary state (T-state) has the potential to both supply and regulate O 2 transport to cultured hepatocytes in the bioreactor due to its low O 2 affinity. In this study, T-state PolyhHb production and purification processes were optimized to minimize the concentration of low-molecularweight PolyhHb species in solution. Deconvolution of size-exclusion chromatography spectra was performed to calculate the distribution of polymeric Hb species in the final product. Fluid flow and mass transport within a single fiber of a hepatic HF bioreactor was computationally modeled with finite element methods to simulate the effects of employing T-state PolyhHb to facilitate O 2 transport in a hepatic bioreactor system. Optimal bioreactor performance was defined as having a combined hypoxic and hyperoxic volume fraction in the extracapillary space of less than 0.05 where multiple zones were observed. The Damköhler number and Sherwood number had strong inverse relationships at each cell density and fiber thickness combination.
| INTRODUCTION
Hepatic hollow fiber (HF) bioreactors have the potential to support patients who are suffering from acute liver failure. 1 Cell culture media used to provide nutrients to hepatocytes in HF bioreactors must be supplemented with an oxygen (O 2 ) carrier in order to provide O 2 offloading ability. To date, there is no practical O 2 carrier for use in HF bioreactors such as those employed as a bioartificial liver assist devices. 2 Because red blood cells (RBCs) undergo hemolysis in these devices, blood is an ineffective choice for use as an O 2 carrier in the perfusate. 3 Therefore, the goal of this work is to create a perfusate that can adequately oxygenate the high cell density found in the extracapillary space (ECS) of HF bioreactors. Given that hemoglobin (Hb) is the natural O 2 transport molecule in vivo, 4 Hb is a potential choice for improving O 2 transport in an HF bioreactor. However, the small size of Hb [molecular weight (MW) of 64 kDa and an effective diameter of 5 nm] limits its application in a perfusate solution. 5 This free protein, as well as other low MW Hb species (<500 kDa), are small enough to extravasate through the membrane in the HF bioreactor. After extravasating into the ECS, Hb can come in to direct contact with cells residing in the ECS. When in direct contact with the cells in the ECS, the reactive O 2 species generated by unmodified Hb result in oxidative tissue damage and cell death. 6, 7 To prevent these harmful effects, Hb can be modified to create an Hb-based O 2 carrier (HBOC). 8, 9 HBOCs are a promising class of RBC substitute. Popular forms of Hb modification include PEGylation, surface conjugation, encapsulation, and polymerization. 10, 11 Of these, polymerized Hb (PolyHb) is the most viable due to its low cost and scalability. 11 Polymerization of Hb with glutaraldehyde as a nonspecific crosslinker is a common strategy used in the synthesis of previous generations of PolyHbs. 12 However, these earlier generation PolyHbs were not effective because they contained large amounts of free Hb and other low MW polymeric Hb species. [13] [14] [15] Previous studies have shown that the average size of PolyHb can be altered by varying the molar ratio of glutaraldehyde to Hb. While this modification increases the average MW of PolyHb, it does not eliminate the presence of low MW polymeric Hb species. 16, 17 To address this issue, a two-stage tangential flow filtration (TFF) system can be employed. 18, 19 The product is first passed through a 0.2 μm TFF filter cartridge to remove large PolyHb aggregates. It is then diafiltered over a TFF filter cartridge with MW cutoff on the order of hundreds of kDa to remove as much low MW PolyHb as possible. The final PolyHb product would then have a viable MW distribution for use in bioreactor or ex vivo organ circuits.
The primary drawback of hepatic HF bioreactors is insufficient O 2 transport to support a high density of hepatocytes in the ECS. 20, 21 Ideally, O 2 transport across the membrane would be regulated to mirror the hepatic O 2 gradient observed in vivo. Prior research has demonstrated that polymerized human Hb (PolyhHb) frozen in the tense quaternary state (T-state) can regulate O 2 transport to cells housed in the ECS. 17 This can prevent the development of hypoxia and hyperoxia, allowing the hepatocytes to function more effectively.
Additionally, hepatic cells must be exposed to a range of physiological O 2 concentrations as observed in the liver sinusoid, which is known as zonation, to properly function. 1, 22 This study builds on previous work and explores a method of quantifying zonation as well as general bioreactor performance. The HF length, single capillary system radius, perfusate flow rate, inlet O 2 partial pressure (pO 2,in ), HBOC concentration, and cell density were varied to determine their effect on bioreactor operation. Two dimensionless numbers, the Damköhler number and Sherwood number, were calculated within the bioreactor system, and their relationship to overall bioreactor performance and zonation was evaluated. The primary objective was to determine which variables and dimensionless numbers strongly correlate to bioreactor performance and zonation. 
| MATERIALS AND METHODS

| Materials
| PolyhHb synthesis
Human hemoglobin (hHb) was first purified via TFF as described by Palmer et al. 23 Glutaraldehyde was used as the crosslinking agent at a 30:1 molar ratio of glutaraldehyde to hHb as described previously. 24, 25 The hHb was diluted to 40 ± 5 g/L in phosphate-buffered saline (PBS) (0.1 M, pH 7.4) and filtered through a 0.2 μm polysulfone (PS) TFF module to remove any large aggregates formed during cryogenic storage.
The hHb was further diluted with PBS to a total working volume of 1,500 ml at a concentration of 19.5 ± 1 g/L. The solution was then added to an airtight glass reaction vessel. The solution was mixed continuously with a stir bar and constant temperature was maintained by placing the reaction vessel in a water bath at 37 C. The hHb solution was deoxygenated via continuous recirculation through a 3M MiniModule gas exchange membrane (Maplewood, MN). The solution partial pressure of dissolved O 2 (pO 2 ) was verified on a Rapidlab 248 (Siemens, Malvern, PA) blood gas analyzer (BGA). Once the pO 2 was below 10 mmHg, Na 2 S 2 O 4 was used to remove the remaining O 2 dissolved in solution. An initial bolus addition of 300 mg was dissolved in 50 ml PBS sparged with nitrogen (N 2 ), followed by four 50 mg additions in 1 ml deoxygenated PBS over 15 min intervals. A final BGA reading was taken to ensure the pO 2 was below detectable levels (<0 mmHg).
A 30:1 molar ratio of glutaraldehyde to hHb was then added to the reactor at 2 ml/min using a syringe pump (New Era Pump Systems, Farmingdale, NY). After the glutaraldehyde addition was completed, the solution was allowed to polymerize for 2 hr under positive N 2 pressure in the reactor headspace.
The polymerization reaction was then quenched at ambient temperature (20 C) with a 7:1 molar ratio NaCNBH 3 to glutaraldehyde.
The addition of NaCNBH 3 also reduces the Schiff bases in solution and minimizes methemoglobin (metHb) levels in the final product. The PolyhHb solution was quenched at ambient temperature for 30 min and then the vessel was stored at 4 C overnight. concentration of the permeate of the 500 kDa TFF cartridge was measured using a UV-vis spectrometer (Olis Inc., Bogart, GA) to validate that the free hHb concentration was less than 1 mg/ml. 26 The PolyhHb solution was concentrated to a final PolyhHb concentration greater than 10 g/dL. The cyanomethemoglobin method was used to measure the metHb level and final concentration of the PolyhHb solution. 27 The final product was stored at −80 C. All tubing and equipment was sterilized using 0.1 M NaOH.
| PolyhHb purification and diafiltration
| Oxygen equilibrium measurements
O 2 equilibrium curves (OEC) for hHb and PolyhHb were measured using a Hemox Analyzer (TCS Scientific Corp., New Hope, PA) at 37 C (physiological temperature). The O 2 binding data from these experiments were fit to the Hill equation to regress the resultant partial pressure of O 2 at which 50% of the hHb or PolyhHb is saturated with O 2 (P 50 ) and cooperativity coefficient (n). 28 
| Size-exclusion chromatography
High-performance liquid chromatography (HPLC) coupled with sizeexclusion chromatography (SEC) was performed with an Ultimate 3000 system using an SEC-1000 column (ThermoFisher Scientific, Waltham, MA). The absorbance was measured at 412 nm to monitor the Soret peak of Hb in the sample. The resultant intensity versus time data was scaled such that the maximum intensity for each run was set to 1. These data were then used to determine the size and MW of the PolyhHbs.
| Spectral deconvolution
SEC data were analyzed using a novel computational program in RStudio (Version 1.1.456, RStudio, Inc., Boston, MA). PolyhHbs of different sizes were characterized by their "polymer order" (n o ), which corresponds to how many times the Hb polymer doubled in size to reach its current mass. This was defined as
where N Hb is the number of hHb tetramers in the Hb polymer.
Since the MW of a single hHb tetramer is 64 kDa, Equation (1) was scaled to
such that a zeroth-order polymer (unpolymerized hHb) corresponds to 1 hHb tetramer in Equation (1) 
| Auto-oxidation
A representative sample of 30:1 T-state PolyhHb was removed from cryogenic storage and allowed to thaw. The sample was then diluted to 12.5 mg/ml, which corresponds to a typical HBOC concentration in the circulation immediately after transfusion as well as the primary PolyhHb concentration in the bioreactor simulations. 29, 30 The 630 nm peak of the sample was monitored over 24 hr by UV-vis spectrometry. The cuvette was kept at 37 C to replicate physiological conditions. The same protocol was repeated for hHb as a control for metHb levels over time. 
| Model hepatic HF bioreactor
| Dimensionless numbers
To assess PolyhHb-mediated mass transfer of O 2 from the HF lumen into the ECS, we examined the Sherwood number, also known as the mass-transfer Nusselt number, which is calculated as shown below.
where R lumen is the outer radius of the lumen, D O2 is the diffusivity of O 2 in the lumen, and k c is the mass transfer coefficient, which was calculated as follows: 
where [O 2 ] ECS is the concentration of O 2 in the ECS, and the residence time is defined as follows:
where V ECS is the volume of the ECS and Q in is the total volumetric flow rate of PolyhHb supplemented media in the system. 
Unfortunately, the theoretical Damköhler number uses the average ECS O 2 concentration, which is difficult to measure within the bulk of large HF modules that can contain bundles of more than 1,000
fibers. Because of this limitation, we also define a practical Damköhler (Da pract ) number that uses the average of the inlet and outlet O 2 concentrations as an approximation. Since the latter is more straightforward to measure during the experimental operation of the bioreactor, it is primarily presented in our analysis.
| Zonation
The bioreactor volume is divided into five zones based on the pO 2 present. The thresholds for each zone are given below: 
where V f, i is the volume of the ith zone, and n f is the total number of zones considered. For our model, we only considered pericentral, perivenous, and periportal regions so n f was set to 3.
| RESULTS AND DISCUSSION
There are multiple biophysical metrics to assess the efficacy of Poly-hHb as an HBOC. Table 1 
| Protein concentrations
The 30:1 T-state PolyhHb produced was concentrated to 10.1 ± 0.6 g/dl. This concentration is comparable to previous commercial HBOCs: PolyHeme 10 g/dl 31 and Hemolink 9.7 g/dl. 32 The metHb level of the final PolyhHb was more than double that of unmodified hHb. This can be explained by two different steps in the synthesis procedure. During polymerization, hHb in the reactor was maintained at 37 C for approximately 2 hr. While the reaction was eventually quenched with NaCNBH 3 , which reduces metHb in solution, there was still an increase in the metHb level at this step. Additionally, previous studies have shown that there is auto-oxidation that occurs during TFF purification leading to further increases in the metHb level. 19, 33 Decreasing the temperature during TFF can lead to less metHb formation, so the solution temperature during TFF was reduced from 4 C to approximately 0 C by submerging the purification vessels in ice. The resultant metHb levels fell from 6.76 ± 1.3% to 4.69 ± 1.1%
confirming that TFF processing increases metHb levels above that of unmodified hHb. The metHb levels were similar between 30:1 T-state
PolyhHb and commercial HBOCs. The biophysical properties of some previous generation HBOCs are shown in Table 2 .
| Hydrodynamic diameter of PolyhHb
The D PolyhHb of 30:1 T-state PolyhHb (45 ± 11 nm) is significantly larger (p < .05) than the reported diameter of free Hb, 5.5 nm. 34 The increased diameter of PolyhHb will help mitigate the negative side effects associated with free Hb in a bioreactor such as free heme release, extravasation to the cells in the ECS, and oxidative tissue damage. 35 
| Oxygen equilibrium
The O 2 -Hb binding data were fit to the Hill equation. The resulting data and fit are shown in Figure 2 . From this fit, the P 50 and n were determined. The differences between the P 50 and cooperativity in hHb and PolyhHb are shown to be statistically significant. 
| Size-exclusion chromatography
The average SEC curve of 16 PolyhHb batches is shown in Figure 3 .
The PolyhHb displays a relatively Gaussian size distribution, indicating uniform MW dispersion. This is further demonstrated by the narrow standard deviation around the average SEC curve. For comparison, the average curve for unmodified hHb is also shown in Figure 3 . There is minimal overlap between the hHb curve and the PolyhHb curve demonstrating that the final PolyhHb product contains nearly zero hHb. The primary difference between commercial HBOCs and the one synthesized in this study is their size as determined by MW. Previous PolyhHbs such as Hemopure and PolyHeme contain more than 10% unmodified hHb, 31, 38 which has been shown to cause cell toxicity for hepatocytes. 39, 40 PolyhHbs from this study have an average MW that is five to eight times larger than that of previous commercial HBOCs.
| Spectral deconvolution
Equations (1), (2) , and (3) yield Table 3 This deconvolution process was applied to all PolyhHbs synthesized in this study. The results are shown in Figure 5 . It should be noted that only 4.6% of the average PolyhHb synthesized was comprised of polymeric Hb species less than 500 kDa, which has traditionally been the highest MW reported for previous generation HBOCs. 18, 38 As discussed previously, this reduction in low MW Hb species should mitigate many of the negative side effects associated with prior HBOCs.
| Auto-oxidation
Prior literature has demonstrated that Hb oxidizes in a first-order manner. 41, 42 Using this information, the ferrous Hb concentration as a function of time was linearized by taking the natural logarithm of concentration as shown in Figure 6 . k ox , of unmodified Hb agreed with the value previously reported by Meng et al. 43 The auto-oxidation rate 
| Simulated bioreactor
The effect of cell density on the combined hypoxic and hyperoxic fraction at various single capillary system radii, PolyhHb concentrations, and pO 2,in values is shown in Figure 7 . At all system radii, there is an optimal point with minimized hypoxic and hyperoxic conditions.
Decreasing the system radius facilitates higher viable cell densities.
Increasing the pO 2,in from 70 to 90 mmHg results in larger regions of hypoxia and hyperoxia even at optimized cell densities. Increasing the PolyhHb concentration leads to curves with reduced hypoxia/hyperoxia at higher cell densities. This implies that using higher PolyhHb concentrations is one strategy for increasing the maximum viable cell density in a preexisting bioreactor.
The relationship between the theoretical Damköhler number and the combined hypoxic and hyperoxic fraction is shown in Figure 8 . In comparison to the theoretical Damköhler number analyzed in Figure 8 , the practical value follows a similar but not identical trend.
The primary difference is that operating within the optimum range of the theoretical Damköhler number provides a higher probability of F I G U R E 7 Hypoxic and hyperoxic fractions as a function of cell density for various bioreactor configurations and operating conditions. These figures show the hypoxic and hyperoxic fraction for media supplemented with T-state PolyhHb. The average concentration of PolyhHb in the media was varied from 12.5 to 50 mg/ml (rows), the pO 2,in was varied from 70 to 90 mmHg (columns), and the radius of the system was varied from 0.3 to 0.5 mm. For these systems, the fiber length was 17 cm and the flow rate was 0.09 ml/min producing a viable bioreactor configuration. The practical Damköhler number is not as predictive of zonation score with the optimum range still potentially leading to bioreactor configurations with large amounts of hypoxia and hyperoxia.
The effect of the Damköhler number on the zonation score when the data are filtered for viable bioreactor configurations is displayed in The correlation between the zonation score and the volume fraction of each zone in the bioreactor ECS is shown in Figure 11 This study also shows that zonation in a bioreactor can be reasonably quantified via computational modeling. Furthermore, the Damköhler number may predict zonation as well as hypoxic and hyperoxic performance in a hepatic HF bioreactor. This may potentially aid in the optimal design and operation of such a bioreactor.
Additional experimental work is needed to validate these computational findings and determine their application to real-world systems. The average concentration of PolyhHb in the media was varied from 12.5 to 50 mg/ml (rows), the pO 2,in was varied from 80 to 100 mmHg, the radius of the system was varied from 0.3 to 0.8 mm. The fiber length was varied from 3 to 90 cm, the flow rate was varied from 0.03 to 0.7 ml/min, and the cell density was varied from 1 × 10 7 to 1 × 10 9 cells/ml
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